CYP2B6 and meningeal tuberculosis: CSF EFZ concentrations exceeding the estimated in vitro neurotoxic level were observed mainly in the TBM group, particularly in those with one or more CYP2B6 c.516G→T mutations (i.e., those with the GT or TT genotype, corresponding to intermediate or slow EFZ metabolizers, respectively).